List of principal authors | |
Genetics of IBD - case presentation | p. 3 |
Intestinal permeability in Crohn's disease: genetic, environmental, or inflammatory? | p. 7 |
Screening for IBD susceptibility: subclinical markers | p. 17 |
Genetics of IBD: chromosomal studies | p. 22 |
Defining clinical activity in Crohn's disease | p. 32 |
Severe ulcerative colitis in a toddler: a complicated course | p. 43 |
Paediatrics in IBD - epidemiology and risk factors | p. 49 |
The diagnosis of a paediatric inflammatory bowel disease | p. 53 |
Growth failure in children with IBD | p. 65 |
Medical management of IBD: children versus adults | p. 71 |
Nutrition therapy in inflammatory bowel disease | p. 85 |
Early versus late IBD - clinical comments | p. 97 |
Early and late inflammatory bowel disease: differential mechanisms | p. 103 |
Evolution into chronicity | p. 110 |
Ulcerative colitis and multiple organ dysfunction syndrome (MODS) | p. 115 |
Early versus late inflammatory bowel disease: implications for therapy | p. 122 |
Cells of the intestinal mucosa - from inflammation to fibrosis | p. 127 |
Bacteria and gut inflammation: a case report | p. 145 |
Bacteria and gut inflammation | p. 148 |
Dietary components as antigens, haptens and mitogens in the pathogenesis of inflammatory bowel disease | p. 153 |
Use of antibiotics and probiotics in Crohn's disease | p. 158 |
Probiotics in IBD | p. 164 |
Prevention and management of postoperative recurrence in Crohn's disease | p. 173 |
Refractory Crohn's disease - discussion of the case | p. 181 |
Mechanisms of refractoriness in Crohn's disease | p. 185 |
The traditional immunosuppressors | p. 201 |
Novel therapeutic options in Crohn's disease: targeting the MAP kinase pathways | p. 206 |
Refractory Crohn's disease - when is the time for surgery? | p. 214 |
Fistulizing CD: a case report | p. 225 |
Fistulizing Crohn's disease - discussion of the case | p. 233 |
Fistulizing Crohn's disease - medical treatment | p. 239 |
Fistulizing Crohn's disease | p. 245 |
Alternative therapies in inflammatory bowel disease | p. 256 |
Diagnostic and therapeutic challenges in indeterminate refractory colitis | p. 267 |
Indeterminate colitis | p. 274 |
IBD: UC or CD | p. 278 |
The neuromodulation of intestinal inflammation | p. 294 |
Relationship between stress, neuroimmune function and gut inflammation | p. 300 |
Medical therapy of ulcerative colitis | p. 306 |
Postoperative complications after ileal pouch-anal anastomosis | p. 313 |
Complications of the ileoanal pouch: medical complications | p. 329 |
Inflammatory bowel disease: how does basic science help clinical management? | p. 335 |
Index | p. 343 |
Table of Contents provided by Blackwell. All Rights Reserved. |